| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $61.7M | +8.5% |
| SG&A Expense | $25.1M | +14.0% |
| Operating Income | -$91.8M | -16.4% |
| Income Tax | $0 | — |
| Net Income | -$89.1M | -13.2% |
| EPS (Basic) | -$2.25 | -8.7% |
| EPS (Diluted) | -$2.25 | -8.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $66.8M | -70.4% |
| Current Assets | $210.5M | -12.5% |
| Total Assets | $247.2M | -17.2% |
| Current Liabilities | $15.4M | +1.6% |
| Total Liabilities | $24.8M | -3.3% |
| Stockholders' Equity | $222.4M | -18.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$75.1M | -26.2% |
| Capital Expenditures | $2.1M | +121.3% |
| Investing Cash Flow | -$109.2M | -169.0% |
| Financing Cash Flow | $25.2M | -48.7% |
| Free Cash Flow | -$77.2M | -27.7% |